Legal
2 min read
Zantac MDL Moves Forward As Parties Select Cases for Bellwether Trials
On April 1, 2020, the Food and Drug Administration (FDA) requested manufacturers withdraw all prescription and over-the-counter ranitidine (Zantac) drugs from the market. This, after tests, showed the products could contain N-nitrosodimethylamine (NDMA), a potent carcinogen. Meanwhile, many consumers had already filed Zantac lawsuits, claiming…